10.1016/j.crohns.2012.12.006 J
Non-selective c-Met inhibitors include crizotinib (PF-02341066), foretinib (XL-880), cabozantinib (XL-184), glesatinib (MGCD265), BMS-777607, and MK2461, which in addition to c-Met, can inhibit other tyrosine kinases, such as ALK, RON, VEGFR2, KIT, TIE2, PDGFR, VEGFR1, VEGFR3, RET, and FLT-3 [163,164,165], through binding to the ATP binding site on tyrosine kinases
Several authors have suggested [59, 92] that Prx2 can also have an important role in erythropoiesis
Understanding these mechanisms helps clinicians determine whether the elevation is benign or indicative of significant pathology
This guide is for anyone asking how fast glutathione works and what to realistically expect
Pairs the calculator with an emergency-response workflow